A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female Participants
Clinical trial NCT03151486 · COMPLETED
Trial details
- NCT number
- NCT03151486
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2018-03-08
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.